• #10 Telehealth Regulations, Opioids, and Substance Use Treatment

  • Sep 30 2022
  • Length: 31 mins
  • Podcast

#10 Telehealth Regulations, Opioids, and Substance Use Treatment

  • Summary

  • Continued access to telehealth services, particularly as it relates to medication assisted treatment (MAT) for substance use disorders (SUDs), enjoys strong support and is an issue worth keeping an eye on. Nate Lacktman and Sunny Levine of the prestigious law firm of Foley & Lardner discuss the current state of telehealth regulations in the wake of COVID-19, which saw the expansion of telehealth services for people with substance use disorders, including opioid and alcohol use disorder.

    However, with each passing month, it appears the COVID-19 public health emergency (PHE) is more likely to come to an end, and along with it the waivers that have allowed providers in much of the country to write prescriptions for MAT such as buprenorphine with naloxone for opioid use disorders (OUDs)--a scenario referred to as the Telehealth Cliff.

    In this Episode, Nate and Sunny talk about the future of MAT, the importance of ePrescribing for SUDs and OUDs, pending legislation or rulemaking that could make virtual MAT permanent, and how the public can help influence upcoming decisions on ePrescribing policies.

    Show More Show Less

What listeners say about #10 Telehealth Regulations, Opioids, and Substance Use Treatment

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.